Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 6:04 pm Sale | 13G | Mersana Therapeutics Inc. MRSN | Rho Ventures V L.P. | 604,213 0.600% | -726,974 (-54.61%) | View |
| 2023-02-13 12:57 pm Sale | 13G | NGM BIOPHARMACEUTICALS INC NGM | Rho Ventures V L.P. | 430,783 0.500% | -3,372,487 (-88.67%) | View |
| 2021-02-16 2:53 pm Purchase | 13G | NGM BIOPHARMACEUTICALS INC NGM | Rho Ventures V L.P. | 3,803,270 5.500% | 12,604 (+0.33%) | View |
| 2021-02-12 5:25 pm Purchase | 13G | NGM BIOPHARMACEUTICALS INC NGM | Rho Ventures V L.P. | 3,790,666 5.500% | 6,000 (+0.16%) | View |
| 2020-02-11 4:58 pm Purchase | 13G | NGM BIOPHARMACEUTICALS INC NGM | Rho Ventures V L.P. | 3,784,666 5.700% | 3,784,666 (New Position) | View |